Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
mRNA-1010 seasonal influenza vaccine study
NCT05415462Phase 3Completed
- Sponsor
- Moderna Inc
- Start
- Jun 2022
- Primary completion
- Sep 2023
- Modality
- Vaccines & Immunotherapeutics, Lipid-based Nanoparticles, mRNA Therapeutics
- Countries
- 5
01
Overview
A Phase 3 trial of mRNA-1010 in seasonal influenza, sponsored by Moderna Inc. Started Jun 2022; status: completed.
02
Drugs
mRNA-1010
03
Conditions
seasonal influenza
Beyond the preview
Go deeper on NCT05415462.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05415462.